Literature DB >> 22902080

Diagnosis of tuberculosis infection based on synthetic peptides from Mycobacterium tuberculosis antigen 85 complex.

Rajpal S Kashyap1, Seema D Shekhawat, Amit R Nayak, Hemant J Purohit, Girdhar M Taori, Hatim F Daginawala.   

Abstract

AIM: The laboratory diagnosis of pulmonary tuberculosis (TB) and tuberculous meningitis (TBM) is particularly challenging. The aim of the present work is to develop an immunoassay for the diagnosis of TB infection, using synthetic peptides of antigen (Ag) 85 complex of M. tuberculosis (Mtb) H37Rv.
METHODS: Four peptides (7-10 amino acids long) corresponding to group-specific epitopes of Ag 85 complex of Mtb were synthesized. All peptides were evaluated by enzyme-linked immunosorbent assay (ELISA) for immunoreactivity with sera and CSF samples of TB and TBM patients respectively. The diagnostic value of the four peptides was evaluated in both the samples.
RESULTS: It was observed that Ag 85 peptide 1, 3 and 4 had the highest positive rates in the pulmonary patients; however, Ag 85 peptide 1 and 2 had shown good positivity in the TBM subjects.
CONCLUSIONS: The synthetic peptide based ELISA using Ag 85 complex peptides is a sensitive, specific, rapid and cost effective immunoassay for early diagnosis of pulmonary and extrapulmonary TB. In addition, these synthetic peptides are comparatively easy to produce in a reproducible manner compared with the whole antigen.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22902080     DOI: 10.1016/j.clineuro.2012.07.031

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  6 in total

1.  Prime-boost with Mycobacterium smegmatis recombinant vaccine improves protection in mice infected with Mycobacterium tuberculosis.

Authors:  Ana Paula Junqueira-Kipnis; Fábio Muniz de Oliveira; Monalisa Martins Trentini; Sangeeta Tiwari; Bing Chen; Danilo Pires Resende; Bruna D S Silva; Mei Chen; Lydia Tesfa; William R Jacobs; André Kipnis
Journal:  PLoS One       Date:  2013-11-08       Impact factor: 3.240

2.  Comparative evaluation of booster efficacies of BCG, Ag85B, and Ag85B peptides based vaccines to boost BCG induced immunity in BALB/c mice: a pilot study.

Authors:  Aliabbas A Husain; Shubhangi R Warke; Dewanand R Kalorey; Hatim F Daginawala; Girdhar M Taori; Rajpal S Kashyap
Journal:  Clin Exp Vaccine Res       Date:  2015-01-30

3.  Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins.

Authors:  Luciano Piubelli; Manuela Campa; Caterina Temporini; Elisa Binda; Francesca Mangione; Massimo Amicosante; Marco Terreni; Flavia Marinelli; Loredano Pollegioni
Journal:  Microb Cell Fact       Date:  2013-11-19       Impact factor: 5.328

4.  A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.

Authors:  Adeliane Castro da Costa; Abadio de Oliveira Costa-Júnior; Fábio Muniz de Oliveira; Sarah Veloso Nogueira; Joseane Damaceno Rosa; Danilo Pires Resende; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

5.  Antigen 85B peptidomic analysis allows species-specific mycobacterial identification.

Authors:  Wei Zhang; Qingbo Shu; Zhen Zhao; Jia Fan; Christopher J Lyon; Adrian M Zelazny; Ye Hu
Journal:  Clin Proteomics       Date:  2018-01-08       Impact factor: 3.988

6.  Mycobacterium tuberculosis pili (MTP), a putative biomarker for a tuberculosis diagnostic test.

Authors:  Natasha Naidoo; Saiyur Ramsugit; Manormoney Pillay
Journal:  Tuberculosis (Edinb)       Date:  2014-03-20       Impact factor: 3.131

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.